Is Overexpression of the Plasma Membrane Transporter () a New Option to Stratify Patients with High-Risk Neuroblastoma for Treatment with I-mIBG?

J Pharmacol Exp Ther

Preclinical Sciences and Translational Safety, Janssen Pharmaceuticals, Spring House, Pennsylvania

Published: December 2023

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.123.001875DOI Listing

Publication Analysis

Top Keywords

overexpression plasma
4
plasma membrane
4
membrane transporter
4
transporter option
4
option stratify
4
stratify patients
4
patients high-risk
4
high-risk neuroblastoma
4
neuroblastoma treatment
4
treatment i-mibg?
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!